These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 688243)

  • 1. Adriamycin and mitomycin C: possible synergistic cardiotoxicity.
    Buzdar AU; Legha SS; Tashima CK; Hortobagyi GN; Yap HY; Krutchik AN; Luna MA; Blumenschein GR
    Cancer Treat Rep; 1978 Jul; 62(7):1005-8. PubMed ID: 688243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
    Andersson M; Daugaard S; von der Maase H; Mouridsen HT
    Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intra-arterial infusion chemotherapy with anticancer agents for advanced breast cancer--effect and toxicity of mitomycin C and adriamycin].
    Toda K; Asaishi K; Okazaki A; Okazaki Y; Okazaki M; Ebata T; Totsuka M; Hayasaka H; Sato N; Narimatsu E
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2298-304. PubMed ID: 2934023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone (CMFVP).
    DiStefano A; Yap HY; Blumenschein GR
    Cancer Treat Rep; 1981; 65(1-2):33-8. PubMed ID: 7013977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of adriamycin and dibromodulcitol in metastatic breast carcinoma.
    Tormey DC; Simon R; Falkson G; Bull J; Band P; Perlin E; Blom J
    Cancer Res; 1977 Feb; 37(2):529-34. PubMed ID: 832277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
    Chang YC; Falkson G; Tormey DC; Crowley J
    Am J Clin Oncol; 1982 Oct; 5(5):521-5. PubMed ID: 7180830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
    Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Tada A; Ueno K; Yamazaki H; Nakamura T; Ito Y; Inagaki J
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):327-32. PubMed ID: 2494947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A; Pronzato P; Conte PF; Rosso R
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C.
    Villani F; Comazzi R; Lacaita G; Guindani A; Genitoni V; Volonterio A; Brambilla MC
    Med Oncol Tumor Pharmacother; 1985; 2(2):93-7. PubMed ID: 3932789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.
    Swain SM; Whaley FS; Ewer MS
    Cancer; 2003 Jun; 97(11):2869-79. PubMed ID: 12767102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effect of stage III breast cancer--comparative study of preoperative intra-arterial infusion chemotherapy and non-infusion therapy].
    Masuoka H; Asaishi K; Toda K; Okazaki M; Okazaki Y; Hayasaka H; Miyake H; Mori M
    Gan To Kagaku Ryoho; 1989 May; 16(5):2067-73. PubMed ID: 2543329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancer.
    Ratanatharathorn V; Samson MK; Baker LH; Pollard R; Cummings G; Fraile RJ
    Am J Clin Oncol; 1983 Oct; 6(5):565-70. PubMed ID: 6412538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-FU/ADR/MMC combined hepatic infusion in liver metastases from gastric cancer].
    Arai Y; Kido C; Endo T; Miyake Y; Sato Y; Ozawa H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2433-6. PubMed ID: 3415254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin, doxorubicin, and vinblastine as second-line chemotherapy in patients with advanced breast cancer.
    Borovik R; Epelbaum R; Cohen Y; Robinson E
    Cancer Treat Rep; 1986 Apr; 70(4):517-8. PubMed ID: 3698045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.